HIF-1α induces angiogenesis and glycolysis by activating the expression of vascular endothelial growth factor (VEGF), glucose transporter (Glut), and glycolysis-related enzymes to control the transfer of oxygen and nutrients and improve the growth and proliferation of cancer cells. Here, SLC2A1 is linked to cancer.